Analysis of circulating cell-free DNA identifies multi-clonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors

Approximately 20% of metastatic prostate cancers harbor mutations in genes required for DNA repair by homologous recombination (HRR) such as BRCA2. HRR defects confer synthetic lethality to PARP inhibitors (PARPi) such as olaparib and talazoparib. In ovarian or breast cancers, olaparib resistance ha...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Discov
Hoofdauteurs: Quigley, David, Alumkal, Joshi J., Wyatt, Alexander W., Kothari, Vishal, Foye, Adam, Lloyd, Paul, Aggarwal, Rahul, Kim, Won, Lu, Eric, Schwartzman, Jacob, Beja, Kevin, Annala, Matti, Das, Rajdeep, Diolaiti, Morgan, Pritchard, Colin, Thomas, George, Tomlins, Scott, Knudsen, Karen, Lord, Christopher J, Ryan, Charles, Youngren, Jack, Beer, Tomasz M., Ashworth, Alan, Small, Eric J., Feng, Felix Y.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581695/
https://ncbi.nlm.nih.gov/pubmed/28450426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0146
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items